Literature DB >> 1355392

Tyrosine-hydroxylase-containing neurons in the primate basal forebrain magnocellular complex.

G K Gouras1, N E Rance, W S Young, V E Koliatsos.   

Abstract

Immunocytochemistry and in situ hybridization for tyrosine hydroxylase (TH) were used to study the distribution of putative catecholaminergic neurons in the basal forebrain magnocellular complex (BFMC) of monkeys and humans. Magnocellular TH-expressing neurons in the primate BFMC are distributed along a rostrocaudal gradient, with the largest proportion of these cells located in the medial septal nucleus and nucleus of the diagonal band of Broca; smaller TH-containing neurons generally follow the same distribution. These findings suggest that, within rostromedial segments of the BFMC, there is a distinct subpopulation of neurons that express catecholamine-synthesizing enzymes. Further research is necessary to establish whether these neurons utilize one or more catecholamines as neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355392     DOI: 10.1016/0006-8993(92)90907-q

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease.

Authors:  M-Marsel Mesulam
Journal:  J Comp Neurol       Date:  2013-12-15       Impact factor: 3.215

2.  Gene Profiling of Nucleus Basalis Tau Containing Neurons in Chronic Traumatic Encephalopathy: A Chronic Effects of Neurotrauma Consortium Study.

Authors:  Elliott J Mufson; Bin He; Stephen D Ginsberg; Benjamin A Carper; Gayle S Bieler; Fiona Crawford; Victor E Alvarez; Bertrand R Huber; Thor D Stein; Ann C McKee; Sylvia E Perez
Journal:  J Neurotrauma       Date:  2018-04-05       Impact factor: 5.269

Review 3.  Review: Revisiting the human cholinergic nucleus of the diagonal band of Broca.

Authors:  A K L Liu; E J Lim; I Ahmed; R C-C Chang; R K B Pearce; S M Gentleman
Journal:  Neuropathol Appl Neurobiol       Date:  2018-08-13       Impact factor: 8.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.